Enfusion's market cap is currently ―. The company's EPS TTM is $0.048; its P/E ratio is 197.73; Enfusion is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 52.57M	$ 44.36M	$ 39.61M	$ 38.00M	$ 40.52M
Gross Profit	$ 73.73M	$ 44.20M	$ 28.51M	$ 27.67M	$ 27.22M
EBIT	$ 2.18M	$ 3.03M	$ 1.19M	$ 5.09M	$ 782.00K
EBITDA	$ 5.77M	-	$ 3.27M	$ 4.22M	$ -9.00K
Net Income Common Stockholders	$ -9.25M	$ 11.70M	$ 629.00K	$ 2.94M	$ 494.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 35.60M	$ 31.65M	$ 27.77M	$ 54.60M	$ 62.55M
Total Assets	$ 108.97M	$ 101.74M	$ 94.05M	$ 121.49M	$ 123.78M
Total Debt	$ 15.44M	$ 16.49M	$ 12.81M	$ 13.65M	$ 6.99M
Net Debt	$ -20.17M	$ -15.16M	$ -14.96M	$ -40.94M	$ -55.56M
Total Liabilities	$ 31.49M	$ 28.46M	$ 21.81M	$ 22.35M	$ 20.34M
Stockholders Equity	$ 53.67M	$ 50.73M	$ 48.09M	$ 63.70M	$ 65.01M
Cash Flow	-
Free Cash Flow	$ 9.51M	-	$ 3.80M	$ -1.63M	$ 5.78M
Operating Cash Flow	$ 6.59M	$ 12.11M	$ 6.02M	$ 924.00K	$ 7.52M
Investing Cash Flow	$ -2.29M	$ -2.61M	$ -2.22M	$ -2.55M	$ -1.75M
Financing Cash Flow	$ -579.00K	$ -5.31M	$ -30.84M	$ -6.35M	$ -7.04M

Currency in USD

Enfusion Earnings and Revenue History

Income Statement >

Enfusion Debt to Assets

Balance Sheet >

Enfusion Cash Flow

Cash Flow >

Enfusion Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing